ZTE

ZTE

ZTE Mobile Phones

Open
HomeHealth

Cowdray Park Clinic Starts Offering HIV Prevention Injection

10 months agoMon, 03 Jun 2024 05:55:11 GMT
Share on FacebookShare on TwitterShare on LinkedIn
Cowdray Park Clinic Starts Offering HIV Prevention Injection

Cowdray Park Clinic in Bulawayo is now offering the Long-Acting Injectable, Cabotegravir (CAB-LA) drug, an injectable HIV prevention drug that provides long-acting protection.

As reported by The Sunday News, the first injection of CAB-LA was administered on 10 April in Harare and the jab is administered once in two months.

CAB-LA is being administered under a study called Catalysing Access to New Prevention Products to Stop HIV (CATALYST).

CATALYST is Maximizing Options to Advance Informed Choice for HIV Prevention (MOSAIC)’s flagship product introduction study.

This study aims to provide and assess an enhanced service delivery package that includes oral PrEP, the PrEP ring, and injectable cabotegravir.

Click here: Pindula WhatsApp Channel
wa.me/channel/0029Vb4GVea90x2nCSDImS1b

 

MOSAIC is a five-year global project funded by the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Agency for International Development (USAID) whose primary goal is to help adolescent girls, young women, and other women prevent HIV by accelerating the introduction and scale-up of new and emerging biomedical prevention products.

MOSAIC Project Lead and Co-Principal Investigator of the CATALYST Study, Dr Emily Gwavava, said:

The long-acting injectable cabotegravir (CAB-LA or CAB PrEP) is now available at all six CATALYST study sites — SHAZ! Hub at CitiMed Hospital in Chitungwiza, Ngundu Rural Health Centre, Runyararo Clinic in Masvingo, Plumtree District Hospital, Beitbridge Wellness Centre, and Cowdray Park Clinic.

CAB PrEP was made available to study participants on Monday 20 May 2024. According to the current national guidelines CAB PrEP will not be available to pregnant and breastfeeding women in Zimbabwe although women who fall pregnant while already using CAB PrEP will be allowed to continue.

In randomised controlled trials (HPTN 083 and HPTN 084), CAB-LA demonstrated a 79% relative reduction in HIV risk compared to oral PrEP.

CAB PrEP is also safe for men, but the CATALYST study is specifically for women given their increased vulnerability to HIV. Said Gwavava:

It has a reduced dosing frequency with clients receiving injections every two months. CAB PrEP offers discretion for those not willing to disclose their PrEP use to others. CAB PrEP users have nothing to store or carry before, during, or after the injection.

CAB PrEP reaches maximum protection about one week after the first injection. Users should use additional HIV prevention methods during this time.

The CATALYST study is being implemented in the country by Pangaea Zimbabwe in collaboration with the Ministry of Health and Child Care and the Organisation of Public Health Interventions and Development (OPHID) which launched in June 2023.

The study has been offering women a choice of oral Pre-Exposure Prophylaxis (PrEP) and the dapivirine vaginal ring. Added Gwavava:

In April 2024, the study introduced a third PrEP option, the long-awaited long-acting injectable cabotegravir (CAB-LA or CAB PrEP) so women will be able to choose from oral PrEP, the dapivirine vaginal ring, and CAB PrEP. All three PrEP methods have been demonstrated to reduce the risk of HIV infection and are approved and registered for use in the country.

Gwavava also said CATALYST is a study with a fixed amount of CAB PrEP available for use during the study. Therefore, the number of participants that can be enrolled is limited.

More: Pindula News

Tags

27 Comments

chihera · 10 months ago
kkkk une piont
cde · 10 months ago
vasati vabatwa aids garai makadaromurume vimbika paburi rimwe chete newe mukadzi usabatwa nemademon ekumusha kwenyu ekuda kubuda unofa nemiwo makabatwa dzikamai musawedzera munoga nekukasira kubatwa hakusi kufa asi unogona kungofa uye musaita utsinye kuti tiwande huroyi ihwohwoo mapiritsi aya acharamba vanhu nevanhu vachaarambawo pakupedzisira nyika ichanhuwaaaa
Jahmael Ke @Kgosi De_Ricch · 10 months ago
Cowdray Park massive
Antman · 10 months ago
Bottom line siki and other serious STDs than HIV will moora you
STIs · 10 months ago
Munofa apa muchine vana vadiki vachiri kuda kuchengetwa
Antman · 10 months ago
Bottom-left
101 · 10 months ago
Pamberi ne****
kumbu matuzvex · 10 months ago
This injection is just an experiment on Africans by the imperialists,you will get to see the side effects soon or later mark my words. Kwavo kutida here ku donator that drug?
🦀🦀 · 10 months ago
but une point
smart_money · 10 months ago
Dai vasingakupeyi Dai makapera kare Ne Aids ...hamutendi sei
ok · 10 months ago
its true cause ma-cancer outbreak acho awanda pamwe chete nema-kidney failures
star · 10 months ago
yes yoyoyo akawana nhata ku overspill nekuda ma $1 for 2
Anonymous · 10 months ago
SA samanyika anzwa veduwee nesick, humba achafa nayo chete 9 months achingonhuwa. Wezhira akangoita 2 weeks akapora zvino wasu yaramba kupera. Mhambha ingonaka Pana amai arikunhuwa kunge toilet.
coni · 10 months ago
yoyoyo enda unobaiwa coz une nhata mumuviri
👀👀 · 10 months ago
ichokwadi ndichatomuisa tambo muhuro ndinomubaisa,,,,masigede org
Bones · 10 months ago
It seems rikubaiwa vakadzi chete 🤔🤔
Bones · 10 months ago
Hoo ndiro riya rinonzi chibaya ma**** hanty?
Dolphin 🐬 · 10 months ago
kkkk taura hako siki inokuridza big time
STIs · 10 months ago
Kune imwe type yesiki yekuti unofamba uchinhuwa chete pese pese paunenge uri
STIs · 10 months ago
LIKE CHANCROID CAN STILL MINCE YOUR ****. CONDIMIZE PLUS STOP CHIPFAMBI
Nnnnnnn · 10 months ago
Kwese kufa
STIs · 10 months ago
Musanyeperane. Munowora nhengo nazvo izvo. Kana iri Herpes haipore. Inongochinja nzvimbo chete. Pamwe pacho ikarova kumeso pamwe kumusana. Ukaona bhande ratenderera then waparara
RM · 10 months ago
musvo to the fullest
Eezy · 10 months ago
well done well done at least we are now talking

Leave a Comment


Generate a Whatsapp Message

Buy Phones on Credit.

More Deals
Feedback